Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

162 results about "Pharmacologic effects" patented technology

Pharmacological effect may be defined as the physiological and/or biochemical changes in the body produced by a drug in therapeutic concentration. No drug has a single pharmacological effect. A drug usually produces several pharmacological effects.

Seaweed-derived extract, organism-applied product using the same, and method for extracting seaweed-derived exosome

To scientifically prove a pharmacological effect and to promote effective use for a fucoidan reported effective for increasing an immune strength and anticancer activity.SOLUTION: A raw material, Mozuku, is hydrolyzed (boiled) to provide a low molecular fucoidan. Then, a nano-level particle group is extracted from the low molecular fucoidan through super-centrifugal separation or the like using a supercentrifuge 1. The major part of the particle group is within the size of 50-200 nm, and composed of exosome carrying miRNA or meRNA. Exosome derived from the fucoidan acts both for apoptosis-induction for an abnormal organ suffering from ulcer or cancer and reproduction for promoting growth of a normal organ, and safe and resistant / non-dependent. Thus, the exosome derived from the fucoidan can be adopted for various products such as a medicine.SELECTED DRAWING: Figure 2
Owner:落谷 孝広 +1

Use of novel pomalidomide derivatives in the treatment of brain diseases

The present invention relates to a novel pomalidomide derivative that exhibits improved pharmacological effects compared to pomalidomide, and is used to treat brain diseases. The novel pomalidomide derivative developed in the present invention has excellent binding ability to cereblon, is almost non-cytotoxic, has low possibility of teratogenic side effects, and can regulate TNF-α expression, as well as suppress oxidative stress and has excellent in vivo pharmacokinetic stability, and shows excellent effects of improving the decrease in motor ability, which is a symptom of Parkinson's disease, and increasing the expression of tyrosine hydroxylase, which is decreased in Parkinson's disease, and can be used for the prevention or treatment of brain diseases such as Parkinson's disease.
Owner:AEVIS BIO INC

Antibacterial and acne-removing microemulsion containing plant extract and preparation method thereof

The application discloses a bacteriostatic and acne-removing microemulsion containing plant extracts and a preparation method thereof. The bacteriostatic and acne-removing microemulsion contains a microemulsion loaded with quercetin alone, a microemulsion loaded with sasanquasapernin alone, and a microemulsion loaded with quercetin and sasanquasapernin simultaneously. The bacteriostatic and acne-removing microemulsion containing plant extracts prepared by the application not only solves the problems of stickiness of camellia oil and poor solubility of quercetin, but also has a synergistic inhibitory effect on propionibacterium acnes, achieves the same high-efficiency bacteriostatic effect with a lower drug concentration, saves drug cost, reduces drug irritation, and expands the application of quercetin and sasanquasapernin in the cosmetic and pharmaceutical fields due to the rich pharmacological effect of the plant extracts, low side effect and safety. The microemulsion system prepared by the application is clear, transparent, uniform and stable, the preparation process is simple, the required energy is low, the cost is low, and the system is beneficial to commercial production.
Owner:SOUTH CHINA UNIV OF TECH

Application of xanthoxylin WGX-50 in preparation of anti-aging drugs

The invention discloses a novel medicinal application of xanthoxylin WGX-50, belongs to the field of biological medicines, and particularly discloses an application of xanthoxylin WGX-50 in preparation of anti-aging medicines. The research proves that the xanthoxylin WGX-50 can play a role through a plurality of molecular mechanisms including an insulin longevity signal channel, MAPK, antioxidant and heat shock protein, has a remarkable regulation and control capability on longevity genes daf-16 and skn-1 (mouse homologous genes FOXO1 and Nrf2), and has pharmacological effects of resisting aging and prolonging life.
Owner:SHANGHAI JIAOTONG UNIV

Traditional Chinese medicine composition for relieving acute kidney injury and preparation method thereof

The invention relates to the technical field of traditional Chinese medicine compositions, in particular to a traditional Chinese medicine composition for relieving acute kidney injury and a preparation method thereof.The traditional Chinese medicine composition comprises honeysuckle-derived exosome-like nano-vesicles (HELNVs), and the particle size distribution of the HELNVs is 68.06-164.20 nm. Firstly, the HELNVs retain various bioactive components of honeysuckle, and the HELNVs retain various bioactive components of the honeysuckle; the components can play a stronger pharmacological role through a synergistic effect; secondly, due to the nanoscale particle size (68.06-164.20 nm), the HELNVs can better penetrate through a biological barrier, and the targeting property and the bioavailability are improved; thirdly, the natural source and exosome-like structure of the HELNVs may endow the HELNVs with unique cell affinity, which is beneficial to the interaction of the HELNVs with target cells; finally, the HELNVs are used as a natural nano-carrier, so that the HELNVs have better safety.
Owner:ZHEJIANG UNIV OF TECH

Freckle-removing and whitening traditional Chinese medicine composition, preparation method thereof and freckle-removing and whitening nourishment

The invention relates to the technical field of health-care food, in particular to a freckle-removing and whitening traditional Chinese medicine composition, a preparation method thereof and freckle-removing and whitening nourishment. Effective components of the freckle-removing and whitening traditional Chinese medicine composition are prepared from the following raw materials in parts by weight: 2-6 parts of peach kernels, 1-5 parts of Chinese wolfberry fruits, 1-5 parts of longan aril, 1-5 parts of Chinese dates, 1-4 parts of lily bulbs, 0.5-4 parts of mulberries, 0.2-2.5 parts of poria cocos and 0.1-0.6 part of double-petal red roses. The freckle-removing and whitening traditional Chinese medicine composition has the effect of accelerating melanin dissolution so as to achieve the good effects of removing freckles and whitening the skin color. Meanwhile, the freckle-removing and whitening traditional Chinese medicine composition disclosed by the invention is good in safety, edible, capable of exerting the pharmacological action and synergistic interaction of all the components and multiple in benefits.
Owner:SHANXI ZHENDONG WU HE YI YANG TANG CO LTD

Tetrandrine ferulate and its application in preparing medicine for treating pulmonary fibrosis

The invention discloses a tetrandrine ferulate and its application in the preparation of a medicament for treating pulmonary fibrosis. The pharmacological effects of tetrandrine and ferulic acid, as well as those after salification, are studied. It is found that both have an anti-pulmonary fibrosis effect, and the two can be used in combination to synergistically exert a more excellent anti-pulmonary fibrosis efficacy. At the same time, the solubility of tetrandrine can also be increased. This has not been reported in existing literature. The tetrandrine ferulate of the present invention has lower cytotoxicity, and the cell viability of normal human liver cells LO-2 and human embryonic fibroblasts MRC-5 is higher than that of tetrandrine, which alleviates the burden of liver and lungs to a certain extent and has good safety.
Owner:INSTITUTE OF CHINESE MATERIA MEDICA CHINA ACADEMY OF CHINESE MEDICAL SCIENCES

Application of total flavonoids of chrysanthemum morifolium and metabolites thereof in preparation of uric acid-lowering or liver and kidney protecting drugs or health products

The application discloses application of total flavones of chrysanthemum morifolium ramat and metabolites thereof in preparation of uric acid-lowering or liver and kidney protecting drugs or health care products. The total flavones of chrysanthemum morifolium ramat contain various flavone compounds. In a hyperuricemia model mouse, the total flavones of chrysanthemum morifolium ramat can significantly reduce blood uric acid level, and has a significant protective effect on liver and kidney, and the effect is achieved by inhibiting the activity and expression of xanthine oxidase and adenosine deaminase in the liver, and regulating the expression of uric acid related transporters in the kidney. Meanwhile, metabolites of the total flavones of chrysanthemum morifolium ramat, luteolin-7-O-glucuronide and apigenin-7-O-glucuronide, can also play a pharmacological role in the mouse body. In vitro experiments and mouse primary hepatocytes further prove that luteolin-7-O-glucuronide and apigenin-7-O-glucuronide have an inhibiting effect on the activity and expression level of xanthine oxidase. The application widens the application range of traditional Chinese medicinal materials, and provides a new direction for development of efficient and low-toxic uric acid-lowering and anti-gout drugs or health care products.
Owner:ZHEJIANG UNIV

Traditional Chinese medicine compound screening method based on machine learning

The invention discloses a traditional Chinese medicine compound screening method based on machine learning, and relates to the technical field of biological medicine.According to the traditional Chinese medicine compound screening method, multi-source traditional Chinese medicine compound spleen tonifying related component data are collected and integrated, a data set containing information such as components, medicine effects and indications is constructed, and follow-up model training is supported; utilizing machine learning to train a compound screening model, identifying drug effect related components, predicting effective parts of traditional Chinese medicinal materials of the components, and revealing contribution of the components to the drug effect; structural characteristics of chemical components are extracted, potential pharmacological effects of the chemical components are analyzed, and drug effect and toxicity analysis is supported; and a pharmacodynamic index set is constructed to evaluate the effect, toxicity and timeliness of the components, and support is provided for pharmacodynamic optimization. Animal experiments are combined to verify the synergistic effect among the components, so that the model prediction accuracy is ensured. The proportion of the compound components is adjusted according to the experimental result to maximize the drug effect and reduce the side effect to meet the requirements of different patients.
Owner:THE 964TH HOSPITAL OF THE CHINESE PEOPLES LIBERATION ARMY JOINT LOGISTICS SUPPORT FORCE

A method for extracting effective active ingredients from Buddleja buddlejae and its application

The present invention discloses a method for extracting effective active ingredients from Buddleja buddhist flower and its application. The method comprises the following steps: first subjecting the crushed Buddleja buddhist flower to ethanol reflux extraction and concentration, and then extracting the obtained Buddleja buddhist flower alcohol extract with petroleum ether, ethyl acetate, and n-butanol respectively. The remaining aqueous phase is concentrated under reduced pressure, purified by a D101 macroporous resin column, and the target product obtained after drying is structurally identified as a verbascoside monomer compound. The method of the present invention can better control the quality standards of Buddleja buddhist flower and pave the way for a more in-depth study of its pharmacological effects by effectively separating the verbascoside compounds from the Buddleja buddhist flower, thereby laying the foundation for the clinical development of new drugs with anti-tumor, antioxidant, and immunomodulatory activities.
Owner:YOUJIANG MEDICAL UNIV FOR NATIONALITIES

Liquid preparation of L-serine or a pharmaceutically acceptable salt thereof and preparation method thereof

The present invention discloses a liquid formulation of L-serine or a pharmaceutically acceptable salt thereof and a method for preparing the same. Specifically, the present invention relates to a liquid formulation and a method for preparing the same, wherein the liquid formulation comprises a high concentration of L-serine or a pharmaceutically acceptable salt thereof, has excellent stability and safety, and exhibits excellent pharmacological effects.
Owner:ASTROGEN CO LTD

Olopatadine and brimonidine-containing compound preparation composition for nasal cavity and preparation method thereof

The invention relates to the field of pharmaceutical preparations, and discloses a compound preparation composition containing olopatadine and brimonidine for a nasal cavity and a preparation method of the compound preparation composition. The compound preparation composition for the nasal cavity is prepared from the following components in percentage by weight: 0.01 to 0.5 percent of olopatadine and 0.01 to 0.5 percent of brimonidine. According to the compound preparation composition, olopatadine and brimonidine are combined for use, the curative effect is remarkably improved compared with single-drug treatment, a good synergistic interaction effect is shown, multiple pharmacological effects are achieved through one-time drug administration, and drug use convenience and long-term treatment compliance are greatly improved.
Owner:NANJING DICHANG PHARM TECH CO LTD

Application of monomer poplar bud flavin derived from clinical compound application traditional Chinese medicine in preparation of medicine for treating nerve injury diseases

The invention discloses application of traditional Chinese medicine monomer poplar bud flavin (including homologues thereof and extracts / mixtures containing the same) in preparation of drugs for treating nerve injury diseases and a preparation method of the drugs for treating the nerve injury diseases. The pharmacological action mechanism of the monomer poplar bud flavin is deeply explored, and animal model application effect verification proves that the monomer poplar bud flavin (including homologues thereof and extracts / mixtures containing the homologues) can obviously improve core symptoms of cerebral apoplexy, autism, Alzheimer's disease and depression models, is high in safety, and can be used for preparing a medicine for treating cerebral apoplexy, autism, Alzheimer's disease and depression models. The invention also develops a medicine for treating cerebral apoplexy, autism, Alzheimer's disease and depression, which takes the poplatin as a core component (including homologues of the poplatin and extracts / mixtures containing the poplatin), and is expected to provide new research results and application schemes for treatment of nerve injury diseases such as cerebral apoplexy, autism, Alzheimer's disease, depression and the like. The important significance is realized on improving the treatment effect.
Owner:SOUTHWEST JIAOTONG UNIV

Application of dipsacus asper saponin VI in regulating and controlling differentiation of surface stem cells

According to the application of the dipsacus asper saponin VI in regulating and controlling the differentiation of the surface stem cells, the brand new pharmacological action of the dipsacus asper saponin VI in targeted promotion of the differentiation of the epidermal stem cells is found for the first time, the cognitive limitation of the prior art is broken through, a brand new target spot and direction are provided for research and development of innovative drugs for wound repair, and the application of the dipsacus asper saponin VI in regulating and controlling the differentiation of the epidermal stem cells is realized. A medicine containing teasel saponin VI is adopted, epidermal stem cells are taken as a core target, wound reepithelialization is accelerated by promoting directional differentiation of the epidermal stem cells, the mechanism is clear, the targeting property is high, a core link capable of directly hitting wound healing is adopted, epidermal stem cell differentiation is regulated in a targeted manner, and meanwhile, the medicine has the synergistic effects of resisting inflammation and promoting angiogenesis; the obvious application potential is realized on refractory wounds such as diabetic feet and pressure sores.
Owner:SUZHOU RUIHUA HOSPITAL

Novel crystal form of tegoprazan sulfonic acid salt and pharmaceutical composition comprising the same

Disclosed are a novel crystal form of tegoprazan sulfonic acid salt and a method of preparing a pharmaceutical composition containing the same. More specifically, disclosed are a novel crystal form of tegoprazan sulfonic acid salt, which greatly improves raw material stability, non-hygroscopicity and solubility, and exhibits pharmacological effects comparable to conventional tegoprazan free base forms, and a method of preparing the same. The novel crystal form of tegoprazan sulfonic acid salt has excellent raw material stability, non-hygroscopicity, and solubility and is thus useful for the development of a novel tegoprazan formulation.
Owner:CHONG KUN DANG PHARMACEUTICAL CORP

Phenalide compound and preparation method and application thereof

The invention discloses phthalide compounds as well as a preparation method and application thereof. The phthalide compounds comprise a compound 1 and a compound 2 as well as a preparation method and application thereof. The two compounds are separated and purified from the ethyl acetate extract of the traditional Chinese medicine ligusticum wallichii for the first time. An in-vitro biological activity test shows that the two compounds have obvious inhibitory activity on xanthine oxidase, which indicates that the two compounds can be used as novel potential candidate drugs for treating hyperuricemia and gout. The embodiment of the invention provides a preparation method, structural identification and pharmacological action of the two phthalide compounds, and provides a new strategy for treatment of hyperuricemia and gout diseases.
Owner:SHAANXI UNIV OF CHINESE MEDICINE

Traditional Chinese medicine composition as well as preparation method and application thereof in treating breast cancer

The invention relates to the technical field of mastopathy drugs, in particular to a traditional Chinese medicine composition, a preparation method thereof and application of the traditional Chinese medicine composition in treatment of breast cancer. The traditional Chinese medicine composition is prepared from the following raw materials: radix astragali, cortex moutan, cortex cinnamomi, radix sophorae flavescentis, semen plantaginis, herba ephedrae, rhizoma chuanxiong, spica prunellae, fructus cnidii, semen cuscutae, radix angelicae sinensis, wine-processed fructus ligustri lucidi, radix rehmanniae preparata, rhizoma atractylodis The traditional Chinese medicine composition is reasonable in compatibility of various raw materials, can generate a synergistic effect, has a good treatment effect on breast cancer, treats both symptoms and root causes, combines purgation and tonification, can strengthen the body resistance to eliminate pathogenic factors, reduces toxicity and improves the effect, has a definite drug effect, reduces the possibility of tumor metastasis, enhances the immunity of the organism, and improves the living quality and survival rate of patients. According to the limited preparation method, active ingredients in the medicinal materials can be extracted to the maximum extent, pharmacological action is promoted to be played, the ingredients are natural, side effects are small, and wide application prospects are achieved.
Owner:SHANGHAI HOSPITAL OF TRADITIONAL CHINESE MEDICINE

Lipid-binding oligonucleotide or complex thereof

The present invention addresses the problem of providing a lipid-binding oligonucleotide or a complex thereof that improves pharmacological effects for the liver and even for organs other than the liver. The present invention provides a lipid-binding oligonucleotide represented by general formula (I) or a complex thereof, or provides a pharmaceutical composition including the same. (In the formula, W, L, R1, and R2 have the same meanings as in the specification and the claims.)
Owner:NISSAN CHEM CORP

Use of novel pomalidomide derivative for treating brain disease

PendingEP4484418A1Organic active ingredientsNervous disorderIncreased tyrosineCereblon
The present invention relates to a use of a novel pomalidomide derivative which is for treating brain diseases, and exhibits improved pharmacological effects as compared to pomalidomide. The novel pomalidomide derivative according to the present invention exhibits excellent binding to cereblon, has almost no cytotoxicity, is unlikely to cause teratogenic adverse effects, can control TNF-α expression, exhibits excellent in vivo pharmacokinetic stability while suppressing oxidative stress, ameliorates a decrease in motor function which is a symptom of Parkinson's disease, and increases tyrosine hydroxylase expression which is reduced by Parkinson's disease, and thus can be used for preventing or treating brain diseases such as Parkinson's disease.
Owner:AEVIS BIO INC

Natural raw material synergistic health-care tea drink capable of reducing blood pressure and preparation method of health-care tea drink

PendingCN119896269ATea substituesDigestionSodium cyclamate
The present invention discloses a natural raw material synergistic blood pressure lowering health-care tea drink and a preparation method thereof, and relates to the technical field of health-care tea drinks, the raw materials comprise, by weight, 50 parts of radix glehniae, 20 parts of radix angelicae and 20 parts of fructus psoraleae, and the auxiliary materials comprise, by weight, 3 parts of sodium benzoate, 3 parts of sodium cyclamate, 2 parts of chitosan, 2 parts of xanthan gum, 0.1 part of lemon yellow and 0.1 part of carmine. According to the blood pressure-reducing health-care tea drink with natural raw materials synergistic interaction, the synergistic interaction among the raw materials is realized through the matching effect among the radix glehniae, the fructus psoraleae and the radix angelicae, the radix glehniae has the effects of reducing blood pressure and blood fat, improving digestion, improving sleep and the like, and the radix angelicae has the effects of reducing blood pressure, relieving exterior syndrome, dispelling wind, relieving pain, eliminating dampness, arresting leucorrhea, diminishing swelling, expelling pus and the like; the psoralen has pharmacological effects of strengthening heart, resisting osteoporosis, resisting tumors, resisting oxidation, protecting nerves and the like, and the active component methoxysarin is extracted and added into the tea drink, so that the tea drink can efficiently reduce blood pressure and improve blood circulation.
Owner:YANBIAN UNIV

A novel application of IdeS

This invention provides a novel application of IdeS, which is used to prepare products addressing photoaging of the skin. These products include skincare products and pharmaceuticals for the prevention and / or treatment of photoaging. The pharmaceuticals are in the form of ointments, and the skincare products are used as adjunct treatments for preventing and treating photoaging. IdeS treatment significantly improves the extensive erythema, wrinkles, desquamation, inflammation, and thickened stratum corneum observed in photoaging model mice. It has been developed as a novel biological therapeutic drug with strong pharmacological effects, few side effects, and avoidance of allergic reactions, thus providing a basis for the clinical treatment of photoaging and photodamage.
Owner:YUNNAN UNIV

Liposome composition for oral administration comprising GLP-1 analog and method for preparing same

The present invention relates to a liposome composition for oral administration, the composition comprising a GLP-1 analog. The liposome according to the present invention has both excellent encapsulation efficiency and encapsulation content of the GLP-1 analog drug, and the prepared liposome composition resists digestive enzymes in the gastrointestinal tract and does not easily degrade when administered orally, thus having excellent stability, and has a high absorption rate in the body, and thus exhibits excellent pharmacological effects.
Owner:HANMI PHARM CO LTD

A method for detecting the effective brain-entering components of Uncaria rhynchophylla based on microdialysis-mass spectrometry-patch clamp technology

ActiveCN118150726BComponent separationVeterinary instrumentsHippocampal regionCerebrospinal fluid test
The present invention relates to the technical field of analysis of brain-penetrating components of Uncaria rhynchophylla, and specifically discloses a method for detecting effective brain-penetrating components of Uncaria rhynchophylla based on microdialysis-mass spectrometry-patch clamp technology. The present invention prepares cerebrospinal fluid test solution of SD rats by microdialysis; uses UPLC-Q-TOF-MS technology to quickly and accurately detect the brain-penetrating components of Uncaria rhynchophylla, screens out monomers or effective components that act on brain tissue, and ensures the effectiveness of basic research on Uncaria rhynchophylla; selects the CA1 region of the hippocampus to study the effects of different brain-penetrating components of Uncaria rhynchophylla on neuronal excitability, and analyzes the differences in neuronal excitability and pharmacological effects by whole-cell patch clamp technology to determine the effective brain-penetrating components of Uncaria rhynchophylla. Combining microdialysis, liquid chromatography-mass spectrometry detection and patch clamp technology provides a data basis and scientific basis for the basic research on the effective substances of Uncaria rhynchophylla, and provides a reference for the more in-depth research and development of Chinese medicinal materials / Chinese patent medicines and their effective components that act on the brain.
Owner:CHENGDE MEDICAL UNIV

Application of Laetanine in preparation of medicine for preventing and / or treating gastric ulcer

The invention provides application of Laetanine in preparation of a medicine for preventing and / or treating gastric ulcer, and belongs to the technical field of biological medicine. The medicine prepared from the Laetanine has the effects of relieving gastric ulcer pain, reducing the pH value of gastric juice and reducing the ET-1 content in plasma at the same time. Research confirms that the Lapanine can enable the pH value of gastric juice of a rat to tend to a normal value, increase the contents of PGE2 and T-SOD in plasma and reduce the contents of ET-1, TNF-alpha and IL-6 in the plasma, that is, the Lapanine has the effects of relieving gastric ulcer pain, reducing the pH value of the gastric juice and reducing the content of ET-1 in the plasma at the same time, the specific pharmacological action of the Lapanine in gastric ulcer is further confirmed, and a foundation is laid for clinical use.
Owner:HENAN UNIV OF CHINESE MEDICINE

Component separation method of xanthoceras sorbifolia bunge tea leaf dichloromethane extract

The invention provides a component separation method of a xanthoceras sorbifolia bunge tea leaf dichloromethane extract. Comprising the following steps: step 1, preparing materials and equipment; step 2, extracting and separating: weighing shiny-leaved yellowhorn tea leaf powder, heating, refluxing and extracting by using an ethanol solution, combining extracting solutions, and concentrating under reduced pressure to obtain a total extract; extracting with dichloromethane, concentrating under reduced pressure to obtain 26.1 g of dichloromethane, dissolving the residual methanol extract with 70% methanol water, filtering, performing preparative liquid chromatography, and eluting; 3, through separation and analysis, the four compounds are determined to be quercitrin, quercetin, myricetin and rutin respectively. According to separation results, the xanthoceras sorbifolia bunge tea contains more flavonoid components, and the flavonoid components have the effects of resisting inflammation, resisting oxidation, reducing blood fat and the like and are important components for playing pharmacological effects of the xanthoceras sorbifolia bunge tea.
Owner:INNER MONGOLIA UNIV FOR THE NATITIES

BimBH3 analogue of double-site coupling fatty acid as well as preparation method and application of BimBH3 analogue

The invention discloses a BimBH3 mimic peptide analogue of double-site coupling fatty acid, a preparation method of the BimBH3 mimic peptide analogue and application of the BimBH3 mimic peptide analogue serving as a novel PTPN1 inhibitor to development of long-acting hypoglycemic drugs. The structural general formula of the Bim BH3 mimic peptide analogue is as shown in formula I: # imgabs0 # mimic peptide compound is derived from a core region of a BimBH3 structural domain, the second amino acid is replaced and modified by Fmoc-Lys (Dde)-OH, the N end of a peptide chain is conjugated and modified by fatty monoacid or fatty diacid, the amino group of a side chain of lysine is conjugated and modified by fatty diacid, and the amino group of the side chain of lysine is conjugated and modified by fatty diacid. The compound has better metabolic stability, membrane permeability, pharmacokinetic characteristics and longer pharmacological action time, and shows an excellent long-acting hypoglycemic effect in the body of a type 2 diabetes mellitus model mouse. The compound is prepared by adopting a polypeptide solid-phase synthesis method, and a crude product is purified and freeze-dried to obtain a target compound.
Owner:QINGDAO UNIV OF SCI & TECH

Application of fennel volatile oil in medicine for treating pressure sores

The invention discloses an application of fennel volatile oil in a medicine for treating pressure sores. The fennel volatile oil is used as a unique active component for preparing the medicine for treating the pressure sores. Through deep research on the pharmacological action of the fennel volatile oil and the treatment effect on a pressure sore animal model, it is proved that the fennel volatile oil can effectively promote healing of pressure sores, and a safer and more effective treatment choice can be provided for pressure sore patients.
Owner:CHONGQING MEDICAL UNIVERSITY

Application of a tetrahydroprotoberberine THPB derivative GP10 in preparation of a medicine for improving or treating epilepsy and neuroinflammation

The present application relates to tetrahydroprotoberberine THPB derivatives, and particularly relates to application of a tetrahydroprotoberberine THPB derivative GP10 in preparation of a medicine for improving or treating epilepsy and neuroinflammation; the new candidate compound GP10 discovered by the present application has significant anti-epilepsy activity, not only expands the pharmacological effect spectrum of THPBs, but also provides a new strategy for research and development of anti-epilepsy drugs or auxiliary treatment drugs. Meanwhile, the present application research proves that GP10 can interfere with the structure of DAMP molecules, affect the combination of DAMP molecules and PRR and the downstream signal transduction, and the mechanism is verified through in-vivo and in-vitro experiments, which provides a new theoretical basis and thought for development of anti-inflammatory drugs.
Owner:CHINA PHARM UNIV

Sustained-release pharmaceutical composition comprising GLP-1 receptor agonist

The present invention relates to a sustained-release pharmaceutical composition using a GLP-1 receptor agonist. Specifically, microparticles comprising semaglutide are prepared using a 5-hydroxydopamine-modified self-crosslinkable hyaluronic acid derivative (SAMH) as a carrier, and the semaglutide is gradually released over a long period of time upon injection into the body, thereby providing excellent effects on blood glucose control and weight management. The sustained-release pharmaceutical composition according to the present invention maintains a low viscosity before administration to the human body, thus being easily administered by injection, and is self-crosslinked and hydrogelated after administration to the human body, and thus can maintain the pharmacological effect of the semaglutide for a long period of time with only a single administration.
Owner:AMTIXBIO CO LTD

Heterocyclic derivative

Provided is a novel compound that is useful as an antiviral drug, exhibits strong drug efficacy in low dosages, can be used safely, and has reverse transcriptase inhibitory activity. This compound is expressed by formula (I) (wherein ring A is (i-a) or (i-b) (where R1 represents a halogen or the like, R2 represents a halogen or the like, R3 represents hydrogen or the like, L represents –O– or the like, R4 represents hydrogen or the like, ring B represents an optionally substituted five-membered or six-membered aromatic heterocycle ring or the like, and n represents an integer of 1-3), and Z is (Z) (where each R6 independently represents a halogen or the like, and m represents an integer of 0-2)).
Owner:SHIONOGI & CO LTD